Viewing Study NCT01768195


Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2025-12-27 @ 1:47 PM
Study NCT ID: NCT01768195
Status: UNKNOWN
Last Update Posted: 2017-01-10
First Post: 2013-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module